BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ancona E, Rampado S, Cassaro M, Battaglia G, Ruol A, Castoro C, Portale G, Cavallin F, Rugge M. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol. 2008;15:3278-3288. [PMID: 18726651 DOI: 10.1245/s10434-008-0065-1] [Cited by in Crossref: 171] [Cited by in F6Publishing: 154] [Article Influence: 12.2] [Reference Citation Analysis]
Number Citing Articles
1 Tang H, Tan L, Wang H, Shen Y, Yin J, Fang Y, Wang Q. Is Routine Subcarinal Lymph Node Dissection Necessary in Superficial Esophageal Squamous Cell Carcinoma? A Propensity Score Matching Analysis. J Cancer 2019;10:2350-6. [PMID: 31258738 DOI: 10.7150/jca.30474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Jung J, Park SY, Park S, Park J. Prognostic value of the neutrophil-to-lymphocyte ratio for overall and disease-free survival in patients with surgically treated esophageal squamous cell carcinoma. Tumor Biol 2016;37:7149-54. [DOI: 10.1007/s13277-015-4596-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
3 Shah PM, Gerdes H. Endoscopic options for early stage esophageal cancer. J Gastrointest Oncol. 2015;6:20-30. [PMID: 25642334 DOI: 10.3978/j.issn.2078-6891.2014.096] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
4 Luna RA, Gilbert E, Hunter JG. High-grade dysplasia and intramucosal adenocarcinoma in Barrettʼs esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Current Opinion in Gastroenterology 2012;28:362-9. [DOI: 10.1097/mog.0b013e328353e346] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
5 Ueda T, Dohi O, Naito Y, Yoshida T, Azuma Y, Ishida T, Matsumura S, Kitae H, Takayama S, Mizuno N, Nakano T, Iwai N, Hirose R, Inoue K, Yoshida N, Kamada K, Uchiyama K, Ishikawa T, Takagi T, Konishi H, Nishimura A, Kishimoto M, Itoh Y. Diagnostic performance of magnifying blue laser imaging versus magnifying narrow-band imaging for identifying the depth of invasion of superficial esophageal squamous cell carcinoma. Dis Esophagus 2021;34:doaa078. [PMID: 32691042 DOI: 10.1093/dote/doaa078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Wu J, Chen QX, Shen DJ, Zhao Q. A prediction model for lymph node metastasis in T1 esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2018;155:1902-1908. [PMID: 29233596 DOI: 10.1016/j.jtcvs.2017.11.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
7 Grotenhuis BA, van Heijl M, Wijnhoven BP, van Berge Henegouwen MI, Biermann K, ten Kate FJ, Busch OR, Dinjens WN, Tilanus HW, van Lanschot JJ. Lymphatic micrometastases in patients with early esophageal adenocarcinoma. J Surg Oncol 2010;102:863-7. [PMID: 20872812 DOI: 10.1002/jso.21719] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
8 Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149:302-17.e1. [PMID: 25957861 DOI: 10.1053/j.gastro.2015.04.053] [Cited by in Crossref: 182] [Cited by in F6Publishing: 175] [Article Influence: 26.0] [Reference Citation Analysis]
9 Shemmeri E, Fabian T. Staging of Esophageal Malignancy. Surg Clin North Am 2021;101:405-14. [PMID: 34048761 DOI: 10.1016/j.suc.2021.03.003] [Reference Citation Analysis]
10 Seewald S, Ang TL, Pouw RE, Bannwart F, Bergman JJ. Management of Early-Stage Adenocarcinoma of the Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection. Dig Dis Sci 2018;63:2146-54. [PMID: 29934725 DOI: 10.1007/s10620-018-5158-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
11 Künzli HT, Belghazi K, Pouw RE, Meijer SL, Seldenrijk CA, Weusten B, Bergman J. Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma. United European Gastroenterol J 2018;6:669-77. [PMID: 30083328 DOI: 10.1177/2050640617753808] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Kurtom S, Kaplan BJ. Esophagus and Gastrointestinal Junction Tumors. Surg Clin North Am 2020;100:507-21. [PMID: 32402297 DOI: 10.1016/j.suc.2020.02.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Manner H, Pech O, Heldmann Y, May A, Pauthner M, Lorenz D, Fisseler-Eckhoff A, Stolte M, Vieth M, Ell C. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2015;29:1888-1896. [PMID: 25294553 DOI: 10.1007/s00464-014-3881-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
14 Künzli HT, van Berge Henegouwen MI, Gisbertz SS, van Esser S, Meijer SL, Bennink RJ, Wiezer MJ, Seldenrijk CA, Bergman JJGHM, Weusten BLAM. Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients. Dis Esophagus 2017;30:1-8. [PMID: 28881907 DOI: 10.1093/dote/dox097] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 D’Journo XB, Thomas PA. Current management of esophageal cancer. J Thorac Dis. 2014;6 Suppl 2:S253-S264. [PMID: 24868443 DOI: 10.3978/j.issn.2072-1439.2014.04.16] [Cited by in F6Publishing: 52] [Reference Citation Analysis]
16 Bhatt A, Kamath S, Murthy SC, Raja S. Multidisciplinary Evaluation and Management of Early Stage Esophageal Cancer. Surg Oncol Clin N Am 2020;29:613-30. [PMID: 32883462 DOI: 10.1016/j.soc.2020.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Saunders JH, Al-Zubaidi S, Waller RC, Ortiz-Fernandez-Sordo J, Parsons SL, Ragunath K, Kaye PV; Trent Oesophago-Gastric Unit. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma. Dis Esophagus 2020;33:doz097. [PMID: 32090253 DOI: 10.1093/dote/doz097] [Reference Citation Analysis]
18 Duan X, Shang X, Yue J, Ma Z, Chen C, Tang P, Jiang H, Yu Z. A nomogram to predict lymph node metastasis risk for early esophageal squamous cell carcinoma. BMC Cancer 2021;21:431. [PMID: 33879102 DOI: 10.1186/s12885-021-08077-z] [Reference Citation Analysis]
19 Rizk N. Surgery for esophageal cancer: goals of resection and optimizing outcomes. Thorac Surg Clin 2013;23:491-8. [PMID: 24199699 DOI: 10.1016/j.thorsurg.2013.07.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
20 Dubecz A, Kern M, Solymosi N, Schweigert M, Stein HJ. Predictors of Lymph Node Metastasis in Surgically Resected T1 Esophageal Cancer. Ann Thorac Surg. 2015;99:1879-85; discussion 1886. [PMID: 25929888 DOI: 10.1016/j.athoracsur.2015.02.112] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 8.3] [Reference Citation Analysis]
21 Jain S, Dhingra S. Pathology of esophageal cancer and Barrett's esophagus. Ann Cardiothorac Surg. 2017;6:99-109. [PMID: 28446998 DOI: 10.21037/acs.2017.03.06] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
22 Gertler R, Stein HJ, Schuster T, Rondak IC, Höfler H, Feith M. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer. Ann Surg. 2014;259:96-101. [PMID: 24096772 DOI: 10.1097/sla.0000000000000239] [Cited by in Crossref: 38] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
23 Ma DW, Jung DH, Kim JH, Park JJ, Youn YH, Park H. Predicting lymph node metastasis for endoscopic resection of superficial esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 2019; 157: 397-402. e1. [PMID: 30143376 DOI: 10.1016/j.jtcvs.2018.07.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
24 Fassan M, Realdon S, Pizzi M, Balistreri M, Battaglia G, Zaninotto G, Ancona E, Rugge M. Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis. Dis Esophagus. 2012;25:263-268. [PMID: 21883657 DOI: 10.1111/j.1442-2050.2011.01236.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
25 Zhou Y, Du J, Li H, Luo J, Chen L, Wang W. Clinicopathologic analysis of lymph node status in superficial esophageal squamous carcinoma. World J Surg Oncol. 2016;14:259. [PMID: 27729036 DOI: 10.1186/s12957-016-1016-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
26 Gockel I, Sgourakis G, Lyros O, Polotzek U, Schimanski CC, Lang H, Hoppo T, Jobe BA. Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. Expert Rev Gastroenterol Hepatol. 2011;5:371-384. [PMID: 21651355 DOI: 10.1586/egh.11.33] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
27 Künzli HT, van Berge Henegouwen M, Gisbertz S, Seldenrijk C, Kuijpers K, Bergman J, Wiezer M, Weusten B. Thoracolaparoscopic dissection of esophageal lymph nodes without esophagectomy is feasible in human cadavers and safe in a porcine survival study. Dis Esophagus 2016;29:649-55. [PMID: 26228037 DOI: 10.1111/dote.12395] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
28 Manner H, Wetzka J, May A, Pauthner M, Pech O, Fisseler-Eckhoff A, Stolte M, Vieth M, Lorenz D, Ell C. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns. Dis Esophagus. 2017;30:1-11. [PMID: 26952572 DOI: 10.1111/dote.12462] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
29 Zeki SS, Bergman JJ, Dunn JM. Endoscopic management of dysplasia and early oesophageal cancer. Best Pract Res Clin Gastroenterol 2018;36-37:27-36. [PMID: 30551853 DOI: 10.1016/j.bpg.2018.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Fovos A, Jarral O, Panagiotopoulos N, Podas T, Mikhail S, Zacharakis E. Does endoscopic treatment for early oesophageal cancers give equivalent oncological outcomes as compared with oesophagectomy? Best evidence topic (BET). Int J Surg 2012;10:415-20. [PMID: 22771501 DOI: 10.1016/j.ijsu.2012.06.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
31 Feczko AF, Louie BE. Endoscopic Resection in the Esophagus. Thorac Surg Clin 2018;28:481-97. [PMID: 30268294 DOI: 10.1016/j.thorsurg.2018.07.006] [Reference Citation Analysis]
32 Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol 2018; 24(41): 4698-4707 [PMID: 30416317 DOI: 10.3748/wjg.v24.i41.4698] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
33 Sihag S, De La Torre S, Hsu M, Nobel T, Tan KS, Gerdes H, Shah P, Bains M, Jones DR, Molena D. Defining low-risk lesions in early-stage esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2020:S0022-5223(20)33097-X. [PMID: 33334599 DOI: 10.1016/j.jtcvs.2020.10.138] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
34 Peng GY, Wu YW, Long QL, Chen L, Zhao JJ, Li XH. A new endoscopic classification system of early-stage esophageal carcinoma and its usefulness in assessing the infiltration depth of esophageal carcinoma. Cancer Invest 2011;29:167-72. [PMID: 21261477 DOI: 10.3109/07357907.2010.512601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
35 Kruszewski WJ. Endoscopic methods in the treatment of early-stage esophageal cancer. Wideochir Inne Tech Maloinwazyjne 2014;9:125-30. [PMID: 25097676 DOI: 10.5114/wiitm.2014.41620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
36 Griffin SM, Burt AD, Jennings NA. Lymph node metastasis in early esophageal adenocarcinoma. Ann Surg. 2011;254:731-776; discussion 731-776. [PMID: 21997815 DOI: 10.1097/sla.0b013e318236048b] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
37 Moon SH, Kim HS, Hyun SH, Choi YS, Zo JI, Shim YM, Lee KH, Kim BT, Choi JY. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma. J Nucl Med. 2014;55:743-748. [PMID: 24700884 DOI: 10.2967/jnumed.113.130716] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
38 Konda VJ, Ferguson MK. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how? World J Gastroenterol 2010; 16(30): 3786-3792 [PMID: 20698041 DOI: 10.3748/wjg.v16.i30.3786] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
39 Stein HJ, Schweigert M, Dubecz A. [Early esophageal cancer: pro surgical resection]. Chirurg 2011;82:495-9. [PMID: 21598061 DOI: 10.1007/s00104-010-2038-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
40 Mitobe J, Ikegami M, Urashima M, Takahashi H, Goda K, Tajiri H. Clinicopathological investigation of lymph node metastasis predictors in superficial esophageal squamous cell carcinoma with a focus on evaluation of lympho-vascular invasion. Scand J Gastroenterol. 2013;48:1173-1182. [PMID: 23971724 DOI: 10.3109/00365521.2013.832365] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
41 Kim Evans KF, Mardini S, Salgado CJ, Chen HC. Esophagus and hypopharyngeal reconstruction. Semin Plast Surg 2010;24:219-26. [PMID: 22550442 DOI: 10.1055/s-0030-1255339] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
42 Schlottmann F, Patti MG. Current Concepts in Treatment of Barrett's Esophagus With and Without Dysplasia. J Gastrointest Surg 2017;21:1354-60. [PMID: 28353175 DOI: 10.1007/s11605-017-3371-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
43 Karamchandani DM, Gonzalez RS, Westerhoff M, Westbrook LM, Panarelli NC, Al-Nuaimi M, King T, Arnold CA. Measuring depth of invasion of submucosa - invasive adenocarcinoma in oesophageal endoscopic specimens: how good are we?☆. Histopathology 2021. [PMID: 34519098 DOI: 10.1111/his.14566] [Reference Citation Analysis]
44 Wang A, Lu L, Fan J, Wang S, Chen X. Lymph node metastatic patterns and its clinical significance for thoracic superficial esophageal squamous cell carcinoma. J Cardiothorac Surg 2020;15:262. [PMID: 32958015 DOI: 10.1186/s13019-020-01302-z] [Reference Citation Analysis]
45 Jiang KY, Huang H, Chen WY, Yan HJ, Wei ZT, Wang XW, Li HX, Zheng XY, Tian D. Risk factors for lymph node metastasis in T1 esophageal squamous cell carcinoma: A systematic review and meta-analysis. World J Gastroenterol 2021; 27(8): 737-750 [PMID: 33716451 DOI: 10.3748/wjg.v27.i8.737] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Chen L, Tang K, Wang S, Chen D, Ding K. Predictors of Lymph Node Metastasis in Siewert Type II T1 Adenocarcinoma of the Esophagogastric Junction: A Population-Based Study. Cancer Control 2021;28:10732748211026668. [PMID: 34155922 DOI: 10.1177/10732748211026668] [Reference Citation Analysis]
47 Zhang Y, Ding H, Chen T, Zhang X, Chen WF, Li Q, Yao L, Korrapati P, Jin XJ, Zhang YX, Xu MD, Zhou PH. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort. Clin Gastroenterol Hepatol. 2019;17:73-81.e3. [PMID: 29704682 DOI: 10.1016/j.cgh.2018.04.038] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
48 Qi X, Li M, Zhao S, Luo J, Shao Y, Zhang Z, Chen Y. Prevalence of metastasis in T1b esophageal squamous cell carcinoma: a retrospective analysis of 258 Chinese patients. J Thorac Dis 2016;8:966-76. [PMID: 27162673 DOI: 10.21037/jtd.2016.03.69] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
49 Fotis D, Doukas M, Wijnhoven BP, Didden P, Biermann K, Bruno MJ, Koch AD. Submucosal invasion and risk of lymph node invasion in early Barrett's cancer: potential impact of different classification systems on patient management. United European Gastroenterol J 2015;3:505-13. [PMID: 26668743 DOI: 10.1177/2050640615581965] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
50 Pech O, Manner H, Ell C. Endoscopic resection. Gastrointest Endosc Clin N Am 2011;21:81-94. [PMID: 21112499 DOI: 10.1016/j.giec.2010.10.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
51 Yang J, Lu Z, Li L, Li Y, Tan Y, Zhang D, Wang A. Relationship of lymphovascular invasion with lymph node metastasis and prognosis in superficial esophageal carcinoma: systematic review and meta-analysis. BMC Cancer 2020;20:176. [PMID: 32131772 DOI: 10.1186/s12885-020-6656-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
52 Lutz L, Werner M. [Barrett's esophagus and carcinoma: Recommendations of the S2k guideline 2014 and the S3 guideline 2015]. Pathologe 2016;37:193-8; quiz 199-200. [PMID: 26979429 DOI: 10.1007/s00292-016-0150-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
53 Mao Y, Yu Z, You B, Fang W, Badgwell B, Berry MF, Ceppa DP, Chen C, Chen H, Cuesta MA, D'Journo XB, Eslick GD, Fu J, Fu X, Gao S, He J, He J, Huang Y, Jiang G, Jiang Z, Kim JY, Li D, Li H, Li S, Liu D, Liu L, Liu Y, Li X, Li Y, Mao W, Molena D, Morse CR, Novoa NM, Tan L, Tan Q, Toker A, Tong T, Wang Q, Weksler B, Xu L, Xu S, Yan T, Zhang L, Zhang X, Zhang X, Zhang Z, Zhi X, Zhou Q. Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma. J Thorac Dis 2019;11:319-28. [PMID: 30863610 DOI: 10.21037/jtd.2018.12.07] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
54 Yang D, Othman M, Draganov PV. Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection For Barrett's Esophagus and Colorectal Neoplasia. Clin Gastroenterol Hepatol. 2019;17:1019-1028. [PMID: 30267866 DOI: 10.1016/j.cgh.2018.09.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
55 Choi JY, Park YS, Jung HY, Ahn JY, Kim MY, Lee JH, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Cho KJ, Kim JH. Feasibility of endoscopic resection in superficial esophageal squamous carcinoma. Gastrointest Endosc. 2011;73:881-889, 889.e1-889.e2. [PMID: 21392755 DOI: 10.1016/j.gie.2010.12.028] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
56 Kumarasinghe MP, Armstrong M, Foo J, Raftopoulos SC. The modern management of Barrett's oesophagus and related neoplasia: role of pathology. Histopathology 2021;78:18-38. [PMID: 33382493 DOI: 10.1111/his.14285] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Miyazaki T, Inose T, Tanaka N, Yokobori T, Suzuki S, Ozawa D, Sohda M, Nakajima M, Fukuchi M, Kato H. Management of Barrett’s esophageal carcinoma. Surg Today. 2013;43:353-360. [PMID: 23283352 DOI: 10.1007/s00595-012-0468-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
58 Nobel TB, Barbetta A, Hsu M, Tan KS, Sihag S, Bains MS, Jones DR, Molena D. Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma. J Am Coll Surg 2019;229:366-73. [PMID: 31108196 DOI: 10.1016/j.jamcollsurg.2019.04.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
59 Ning B, Abdelfatah MM, Othman MO. Endoscopic submucosal dissection and endoscopic mucosal resection for early stage esophageal cancer. Ann Cardiothorac Surg. 2017;6:88-98. [PMID: 28446997 DOI: 10.21037/acs.2017.03.15] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 6.6] [Reference Citation Analysis]
60 Yin F, Hernandez Gonzalo D, Lai J, Liu X. Histopathology of Barrett’s Esophagus and Early-Stage Esophageal Adenocarcinoma: An Updated Review. GastrointestDisord 2018;1:147-63. [DOI: 10.3390/gidisord1010011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Mohiuddin K, Dorer R, El Lakis MA, Hahn H, Speicher J, Hubka M, Low DE. Outcomes of Surgical Resection of T1bN0 Esophageal Cancer and Assessment of Endoscopic Mucosal Resection for Identifying Low-Risk Cancers Appropriate for Endoscopic Therapy. Ann Surg Oncol 2016;23:2673-8. [PMID: 27020584 DOI: 10.1245/s10434-016-5138-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
62 Tsou YK, Lee CH, Le PH, Chen BH. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review. Crit Rev Oncol Hematol 2020;147:102883. [PMID: 32014674 DOI: 10.1016/j.critrevonc.2020.102883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
63 Bird-Lieberman EL, Fitzgerald RC. Early diagnosis of oesophageal cancer. Br J Cancer. 2009;101:1-6. [PMID: 19513070 DOI: 10.1038/sj.bjc.6605126] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.5] [Reference Citation Analysis]
64 Nurkin SJ, Nava HR, Yendamuri S, LeVea CM, Nwogu CE, Groman A, Wilding G, Bain AJ, Hochwald SN, Khushalani NI. Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer. Surg Endosc. 2014;28:1090-1095. [PMID: 24232046 DOI: 10.1007/s00464-013-3270-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
65 McCann P, Stafinski T, Wong C, Menon D. The safety and effectiveness of endoscopic and non-endoscopic approaches to the management of early esophageal cancer: a systematic review. Cancer Treat Rev 2011;37:11-62. [PMID: 20570442 DOI: 10.1016/j.ctrv.2010.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
66 Kawaguchi G, Sasamoto R, Abe E, Ohta A, Sato H, Tanaka K, Maruyama K, Kaizu M, Ayukawa F, Yamana N, Liu J, Takeuchi M, Kobayashi M, Aoyama H. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer. Radiat Oncol 2015;10:31. [PMID: 25636830 DOI: 10.1186/s13014-015-0337-4] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
67 Shin KE, Lee KS, Choi JY, Kim HK, Shim YM. Esophageal malignancy and staging. Semin Roentgenol 2013;48:344-53. [PMID: 24034266 DOI: 10.1053/j.ro.2013.03.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
68 Komanduri S, Deprez PH, Atasoy A, Hofmann G, Pokieser P, Ba-Ssalamah A, Collard JM, Wijnhoven BP, Verhage RJ, Brücher B, Schuhmacher C, Feith M, Stein H. Barrett's esophagus: treatments of adenocarcinomas I. Ann N Y Acad Sci 2011;1232:248-64. [PMID: 21950817 DOI: 10.1111/j.1749-6632.2011.06055.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
69 Zhang W, Chen H, Zhang G, Jin G. A nomogram for predicting lymph node metastasis in superficial esophageal squamous cell carcinoma. J Biomed Res 2021;35:361-70. [PMID: 34628403 DOI: 10.7555/JBR.35.20210034] [Reference Citation Analysis]
70 Zeki S, Fitzgerald RC. Targeting care in Barrett's oesophagus. Clin Med 2014;14:s78-83. [DOI: 10.7861/clinmedicine.14-6-s78] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
71 Mao Y, Qiu H, Liu Q, Lu Z, Fan K, Huang Y, Yang Y. Endoscopic holmium:YAG laser ablation of early gastrointestinal intramucosal cancer. Lasers Med Sci 2013;28:1505-9. [PMID: 23329369 DOI: 10.1007/s10103-013-1267-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
72 Ortiz-Fernández-Sordo J, Parra-Blanco A, García-Varona A, Rodríguez-Peláez M, Madrigal-Hoyos E, Waxman I, Rodrigo L. Endoscopic resection techniques and ablative therapies for Barrett’s neoplasia. World J Gastrointest Endosc 2011; 3(9): 171-182 [PMID: 21954414 DOI: 10.4253/wjge.v3.i9.171] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
73 Nentwich MF, von Loga K, Reeh M, Uzunoglu FG, Marx A, Izbicki JR, Bogoevski D. Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus. J Gastrointest Surg. 2014;18:242-249; discussion 249. [PMID: 24091912 DOI: 10.1007/s11605-013-2367-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
74 Marino KA, Sullivan JL, Weksler B. Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study. J Thorac Cardiovasc Surg 2018;155:2211-2218.e1. [PMID: 29455958 DOI: 10.1016/j.jtcvs.2017.11.111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
75 Schlottmann F, Patti MG, Shaheen NJ. Endoscopic Treatment of High-Grade Dysplasia and Early Esophageal Cancer. World J Surg 2017;41:1705-11. [DOI: 10.1007/s00268-017-3977-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
76 Dunn JM, Reyhani A, Santaolalla A, Zylstra J, Gimson E, Pennington M, Baker C, Kelly M, Van Hemelrijck M, Lagergren J, Zeki SS, Gossage JA, Davies AR. Transition from esophagectomy to endoscopic therapy for early esophageal cancer. Dis Esophagus 2021:doab047. [PMID: 34260693 DOI: 10.1093/dote/doab047] [Reference Citation Analysis]
77 Li B, Chen H, Xiang J, Zhang Y, Kong Y, Garfield DH, Li H. Prevalence of lymph node metastases in superficial esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg. 2013;146:1198-1203. [PMID: 23988285 DOI: 10.1016/j.jtcvs.2013.07.006] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
78 Vignesh S, Hoffe SE, Meredith KL, Shridhar R, Almhanna K, Gupta AK. Endoscopic Therapy of Neoplasia Related to Barrett's Esophagus and Endoscopic Palliation of Esophageal Cancer. Cancer Control 2013;20:117-29. [DOI: 10.1177/107327481302000205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
79 Pech O, Alqahtani SA. Update on endoscopic treatment of Barrett's oesophagus and Barrett's oesophagus-related neoplasia. Ther Adv Gastrointest Endosc 2020;13:2631774520935241. [PMID: 32783025 DOI: 10.1177/2631774520935241] [Reference Citation Analysis]
80 Yoon HH, Khan M, Shi Q, Cassivi SD, Wu TT, Quevedo JF, Burch PA, Sinicrope FA, Diasio RB. The prognostic value of clinical and pathologic factors in esophageal adenocarcinoma: a mayo cohort of 796 patients with extended follow-up after surgical resection. Mayo Clin Proc. 2010;85:1080-1089. [PMID: 21123634 DOI: 10.4065/mcp.2010.0421] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
81 Malik S, Sharma G, Sanaka MR, Thota PN. Role of endoscopic therapy in early esophageal cancer. World J Gastroenterol 2018; 24(35): 3965-3973 [PMID: 30254401 DOI: 10.3748/wjg.v24.i35.3965] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
82 Bronson NW, Luna RA, Hunter JG. Tailoring esophageal cancer surgery. Semin Thorac Cardiovasc Surg 2012;24:275-87. [PMID: 23465676 DOI: 10.1053/j.semtcvs.2012.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
83 Namasivayam V, Wang KK, Prasad GA. Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions. Clin Gastroenterol Hepatol. 2010;8:743-54; quiz e96. [PMID: 20541628 DOI: 10.1016/j.cgh.2010.05.030] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
84 Raja S, Rice TW, Goldblum JR, Rybicki LA, Murthy SC, Mason DP, Blackstone EH. Esophageal submucosa: the watershed for esophageal cancer. J Thorac Cardiovasc Surg 2011;142:1403-11.e1. [PMID: 22093714 DOI: 10.1016/j.jtcvs.2011.09.027] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
85 Balalis GL, Thompson SK. Sentinel lymph node biopsy in esophageal cancer: an essential step towards individualized care. Ann Surg Innov Res. 2014;8:2. [PMID: 24829610 DOI: 10.1186/1750-1164-8-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
86 Duan XF, Tang P, Shang XB, Jiang HJ, Yu ZT. The prevalence of lymph node metastasis for pathological T1 esophageal cancer: a retrospective study of 143 cases. Surg Oncol. 2018;27:1-6. [PMID: 29549895 DOI: 10.1016/j.suronc.2017.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
87 Zhuge L, Wang S, Xie J, Huang B, Zheng D, Zheng S, Mao H, Pennathur A, Sanchez MV, Luketich JD, Xiang J, Chen H, Zhang J. A model based on endoscopic morphology of submucosal esophageal squamous cell carcinoma for determining risk of metastasis on lymph nodes. J Thorac Dis 2018;10:6846-53. [PMID: 30746230 DOI: 10.21037/jtd.2018.11.77] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
88 Wang D, Smit JK, Zwaan E, Muijs CT, Groen H, Hollema H, Plukker JT. Neoadjuvant therapy reduces the incidence of nodal micrometastases in esophageal adenocarcinoma. The American Journal of Surgery 2013;206:732-8. [DOI: 10.1016/j.amjsurg.2013.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
89 Markar SR, Hanna G. Minimally invasive esophagectomy for dysplastic Barrett's esophagus. World J Surg 2015;39:608-14. [PMID: 25145822 DOI: 10.1007/s00268-014-2746-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
90 Horváth OP. [Surgical treatment for early Barrett cancer]. Magy Seb 2009;62:51-8. [PMID: 19386564 DOI: 10.1556/MaSeb.62.2009.2.1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
91 Hatzaras I, George N, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Predictors of survival in periampullary cancers following pancreaticoduodenectomy. Ann Surg Oncol. 2010;17:991-997. [PMID: 20108122 DOI: 10.1245/s10434-009-0883-9] [Cited by in Crossref: 102] [Cited by in F6Publishing: 96] [Article Influence: 8.5] [Reference Citation Analysis]
92 Mitchell DP, Yeluri S, Van der Wall H, Falk GL. The real risk of nodal disease in T1 oesophageal adenocarcinoma: A systematic review. Eur Surg 2020;52:110-7. [DOI: 10.1007/s10353-019-00627-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Hiranyatheb P, Osugi H. Radical lymphadenectomy in esophageal cancer: from the past to the present. Dis Esophagus. 2013;Jun 24; Epub ahead of print. [PMID: 23796327 DOI: 10.1111/dote.12091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
94 Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol 2014;27:1578-89. [PMID: 24762549 DOI: 10.1038/modpathol.2014.66] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
95 Aho JM, Nenadic IZ, Aristizabal S, Wigle DA, Tschumperlin DJ, Urban MW. Use of Shear Wave Ultrasound Vibrometry for Detection of Simulated Esophageal Malignancy in Ex Vivo Porcine Esophagi. Biomed Phys Eng Express 2016;2:065002. [PMID: 28948043 DOI: 10.1088/2057-1976/2/6/065002] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
96 Chen H, Zhou X, Tang X, Li S, Zhang G. Prediction of Lymph Node Metastasis in Superficial Esophageal Cancer Using a Pattern Recognition Neural Network. Cancer Manag Res 2020;12:12249-58. [PMID: 33273861 DOI: 10.2147/CMAR.S270316] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Akiyama J, Roorda A, Triadafilopoulos G. Managing Barrett's esophagus with radiofrequency ablation. Gastroenterol Rep (Oxf) 2013;1:95-104. [PMID: 24759814 DOI: 10.1093/gastro/got009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
98 Xie X, Luo K, Hu Y, Wang J, Chen J. Prognostic value of preoperative platelet-lymphocyte and neutrophil-lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer: Preoperative PLR and ESCC outcomes. Dis Esophagus 2016;29:79-85. [DOI: 10.1111/dote.12296] [Cited by in Crossref: 40] [Cited by in F6Publishing: 55] [Article Influence: 5.0] [Reference Citation Analysis]
99 Lee L, Ronellenfitsch U, Hofstetter WL, Darling G, Gaiser T, Lippert C, Gilbert S, Seely AJ, Mulder DS, Ferri LE. Predicting Lymph Node Metastases in Early Esophageal Adenocarcinoma Using a Simple Scoring System. Journal of the American College of Surgeons 2013;217:191-9. [DOI: 10.1016/j.jamcollsurg.2013.03.015] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 6.6] [Reference Citation Analysis]
100 Spataro J, Zfass AM, Schubert M, Shah T. Early Esophageal Cancer: A Gastroenterologist’s Disease. Dig Dis Sci 2019;64:3048-58. [DOI: 10.1007/s10620-019-05817-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
101 Xu W, Liu XB, Li SB, Yang ZH, Tong Q. Prediction of lymph node metastasis in superficial esophageal squamous cell carcinoma in Asia: a systematic review and meta-analysis. Dis Esophagus. 2020;33. [PMID: 32399558 DOI: 10.1093/dote/doaa032] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
102 Sengupta N, Sawhney MS. Advances in Imaging and Endoluminal Therapies for Early Esophageal and Gastric Cancers. Ann Surg Oncol 2016;23:3774-9. [PMID: 27464607 DOI: 10.1245/s10434-016-5425-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
103 Xie X, Zhang SS, Wen J, Yang H, Luo KJ, Yang F, Hu Y, Fu JH. Prognostic value of HOXB7 mRNA expression in human oesophageal squamous cell cancer. Biomarkers. 2013;18:297-303. [PMID: 23627614 DOI: 10.3109/1354750x.2013.773380] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
104 Manner H, Pech O, Heldmann Y, May A, Pohl J, Behrens A, Gossner L, Stolte M, Vieth M, Ell C. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol. 2013;11:630-5; quiz e45. [PMID: 23357492 DOI: 10.1016/j.cgh.2012.12.040] [Cited by in Crossref: 139] [Cited by in F6Publishing: 111] [Article Influence: 15.4] [Reference Citation Analysis]
105 van der Wel MJ, Jansen M, Vieth M, Meijer SL. What Makes an Expert Barrett’s Histopathologist? In: Jansen M, Wright NA, editors. Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract. Cham: Springer International Publishing; 2016. pp. 137-59. [DOI: 10.1007/978-3-319-41388-4_8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
106 Dunki-Jacobs EM, Martin RC. Endoscopic therapy for Barrett's esophagus: a review of its emerging role in optimal diagnosis and endoluminal therapy. Ann Surg Oncol 2012;19:1575-82. [PMID: 22160480 DOI: 10.1245/s10434-011-2163-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
107 Saeed NA, Mellon EA, Meredith KL, Hoffe SE, Shridhar R, Frakes J, Fontaine JP, Pimiento JM, Kothari N, Almhanna K. Adjuvant chemotherapy and outcomes in esophageal carcinoma. J Gastrointest Oncol 2017;8:816-24. [PMID: 29184685 DOI: 10.21037/jgo.2017.07.10] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
108 Andolfo I, Petrosino G, Vecchione L, De Antonellis P, Capasso M, Montanaro D, Gemei M, Troncone G, Iolascon A, Orditura M, Ciardiello F, De Vita F, Zollo M. Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma. BMC Cancer 2011;11:126. [PMID: 21481261 DOI: 10.1186/1471-2407-11-126] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
109 Nelson DB, Dhupar R, Katkhuda R, Correa A, Goltsov A, Maru D, Sepesi B, Antonoff MB, Mehran RJ, Rice DC, Vaporciyan AA, Davila M, Davila R, Betancourt S, Ajani J, Hofstetter WL. Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2018;156:406-413.e3. [PMID: 29605441 DOI: 10.1016/j.jtcvs.2018.02.093] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
110 Nason KS. Minimal or maximal surgery for esophageal cancer? The Journal of Thoracic and Cardiovascular Surgery 2016;151:633-5. [DOI: 10.1016/j.jtcvs.2015.09.118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
111 Haringsma J, van Heel NC, Kuipers EJ. Are we making progress in diagnosing and preventing gastrointestinal cancers? Therap Adv Gastroenterol 2010;3:213-20. [PMID: 21180603 DOI: 10.1177/1756283X10372984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
112 Prenzel KL, Hölscher AH, Drebber U, Agavonova M, Gutschow CA, Bollschweiler E. Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol. 2012;38:314-318. [PMID: 22277724 DOI: 10.1016/j.ejso.2012.01.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
113 Lim JH, Lee SA, Kang GE, Kim JM, Park JK, Chung YJ, Jung JK, Park CK, Kim HS, Lee DW. Esophageal cancer treated by endoscopic submucosal dissection after neoadjuvant chemoradiotherapy: a case report. J Med Case Rep 2014;8:439. [PMID: 25519497 DOI: 10.1186/1752-1947-8-439] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
114 Imai K, Kakushima N, Tanaka M, Takizawa K, Matsubayashi H, Hotta K, Yamaguchi Y, Ono H. Validation of the application of the Japanese curative criteria for superficial adenocarcinoma at the esophagogastric junction treated by endoscopic submucosal dissection: a long-term analysis. Surg Endosc 2013;27:2436-45. [PMID: 23355156 DOI: 10.1007/s00464-012-2755-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
115 Nakagawa K, Koike T, Iijima K, Shinkai H, Hatta W, Endo H, Ara N, Uno K, Asano N, Imatani A, Shimosegawa T. Comparison of the long-term outcomes of endoscopic resection for superficial squamous cell carcinoma and adenocarcinoma of the esophagus in Japan. Am J Gastroenterol. 2014;109:348-356. [PMID: 24394751 DOI: 10.1038/ajg.2013.450] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
116 Koutsoumpas A, Wang LM, Bailey AA, Gillies R, Marshall R, Booth M, Sgromo B, Maynard N, Braden B. Non-radical, stepwise complete endoscopic resection of Barrett's epithelium in short segment Barrett's esophagus has a low stricture rate. Endosc Int Open 2016;4:E1292-7. [PMID: 27995191 DOI: 10.1055/s-0042-118282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
117 Schwameis K, Zehetner J, Green KM, DeMeester SR. Workload, Recurrence, Quality of Life and Long-term Efficacy of Endoscopic Therapy for High-grade Dysplasia and Intramucosal Esophageal Adenocarcinoma. Ann Surg 2020;271:701-8. [PMID: 30247330 DOI: 10.1097/SLA.0000000000003038] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
118 Koike T, Nakagawa K, Iijima K, Shimosegawa T. Endoscopic resection (endoscopic submucosal dissection/endoscopic mucosal resection) for superficial Barrett's esophageal cancer. Dig Endosc 2013;25 Suppl 1:20-8. [PMID: 23480400 DOI: 10.1111/den.12047] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
119 Gamboa AM, Kim S, Force SD, Staley CA, Woods KE, Kooby DA, Maithel SK, Luke JA, Shaffer KM, Dacha S, Saba NF, Keilin SA, Cai Q, El-Rayes BF, Chen Z, Willingham FF. Treatment allocation in patients with early-stage esophageal adenocarcinoma: Prevalence and predictors of lymph node involvement. Cancer. 2016;122:2150-2157. [PMID: 27142247 DOI: 10.1002/cncr.30040] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
120 Li LY, Li EM, Wu ZY, Huang X, Shen JH, Xu XE, Wu JY, Huang Q, Xu LY. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma. Dis Esophagus 2011;24:337-45. [PMID: 21143696 DOI: 10.1111/j.1442-2050.2010.01147.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
121 Chennat J, Konda VJ, Waxman I. Endotherapy for Barrett's esophagus: Which, how, when, and who? Gastrointest Endosc Clin N Am 2011;21:119-33. [PMID: 21112502 DOI: 10.1016/j.giec.2010.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
122 Kauppi J, Gockel I, Rantanen T, Hansen T, Ristimäki A, Lang H, Sihvo E, Räsänen J, Junginger T, Salo JA. Cause of death during long-term follow-up for superficial esophageal adenocarcinoma. Ann Surg Oncol 2013;20:2428-33. [PMID: 23354564 DOI: 10.1245/s10434-013-2866-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
123 Hölscher AH, Bollschweiler E. Frequency of lymph node metastasis in submucosal esophageal cancer. Ann Surg 2014;259:e84. [PMID: 24169170 DOI: 10.1097/SLA.0000000000000298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
124 Liu Y, Yang H, Fu H, Li M, Feng Z, Peng Z, Liang Z, Wang H. Prognostic impact of examined lymph node count in pT1N0M0 esophageal cancer: A population-based study. Thorac Cancer 2019;10:1636-43. [PMID: 31237106 DOI: 10.1111/1759-7714.13130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
125 Lopes AB, Fagundes RB. Esophageal squamous cell carcinoma - precursor lesions and early diagnosis. World J Gastrointest Endosc 2012; 4(1): 9-16 [PMID: 22267978 DOI: 10.4253/wjge.v4.i1.9] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
126 Fernández-Sordo JO, Konda VJ, Chennat J, Madrigal-Hoyos E, Posner MC, Ferguson MK, Waxman I. Is Endoscopic Ultrasound (EUS) necessary in the pre-therapeutic assessment of Barrett's esophagus with early neoplasia? J Gastrointest Oncol 2012;3:314-21. [PMID: 23205307 DOI: 10.3978/j.issn.2078-6891.2012.038] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
127 Zhu LH, Yao J, Wu T, Wang Y, Wang CW, Xue CQ, Wu LG, Fan XW, Wu CY. Risk of Recurrence and Metastasis for Patients with T1N0M0 Esophageal Carcinoma Who Achieve Completed Resection via Endoscopic Submucosal Resection: Evidence for the Appropriateness of the Watch and Wait Follow-Up Strategy. Cancer Manag Res 2020;12:2427-35. [PMID: 32308479 DOI: 10.2147/CMAR.S227959] [Reference Citation Analysis]
128 Hölscher AH, Bollschweiler E, Schröder W, Metzger R, Gutschow C, Drebber U. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg. 2011;254:802-807; discussion 807-808. [PMID: 22042472 DOI: 10.1097/sla.0b013e3182369128] [Cited by in Crossref: 84] [Cited by in F6Publishing: 33] [Article Influence: 8.4] [Reference Citation Analysis]
129 Sgourakis G, Gockel I, Lyros O, Lanitis S, Dedemadi G, Polotzek U, Karaliotas C, Lang H. The Use of Neural Networks in Identifying Risk Factors for Lymph Node Metastasis and Recommending Management of T1b Esophageal Cancer. The American Surgeon 2012;78:195-206. [DOI: 10.1177/000313481207800238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
130 Udagawa H, Ueno M. Comparison of two major staging systems of esophageal cancer-toward more practical common scale for tumor staging. Ann Transl Med 2018;6:76. [PMID: 29666799 DOI: 10.21037/atm.2018.01.27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
131 Low DE. Update on staging and surgical treatment options for esophageal cancer. J Gastrointest Surg 2011;15:719-29. [PMID: 21487832 DOI: 10.1007/s11605-011-1515-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
132 Sepesi B, Watson TJ, Zhou D, Polomsky M, Litle VR, Jones CE, Raymond DP, Hu R, Qiu X, Peters JH. Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg. 2010;210:418-427. [PMID: 20347733 DOI: 10.1016/j.jamcollsurg.2010.01.003] [Cited by in Crossref: 126] [Cited by in F6Publishing: 115] [Article Influence: 10.5] [Reference Citation Analysis]
133 Enestvedt BK, Ginsberg GG. Advances in endoluminal therapy for esophageal cancer. Gastrointest Endosc Clin N Am. 2013;23:17-39. [PMID: 23168117 DOI: 10.1016/j.giec.2012.10.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
134 Manner H, Pech O. Measurement of the tumor invasion depth into the submucosa in early adenocarcinoma of the esophagus (pT1b): Can microns be the new standard for the endoscopist? United European Gastroenterol J 2015;3:501-4. [PMID: 26668742 DOI: 10.1177/2050640615617724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
135 Condon A, Muthusamy VR. The evolution of endoscopic therapy for Barrett's esophagus. Ther Adv Gastrointest Endosc 2021;14:26317745211051834. [PMID: 34708204 DOI: 10.1177/26317745211051834] [Reference Citation Analysis]
136 Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol. 2012;107:850-62; quiz 863. [PMID: 22488081 DOI: 10.1038/ajg.2012.78] [Cited by in Crossref: 150] [Cited by in F6Publishing: 122] [Article Influence: 15.0] [Reference Citation Analysis]
137 Van De Voorde L, Larue RT, Pijls M, Buijsen J, Troost EG, Berbée M, Sosef M, van Elmpt W, Schraepen M, Vanneste B, Oellers M, Lambin P. A qualitative synthesis of the evidence behind elective lymph node irradiation in oesophageal cancer. Radiotherapy and Oncology 2014;113:166-74. [DOI: 10.1016/j.radonc.2014.11.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
138 Benech N, O'Brien JM, Barret M, Jacques J, Rahmi G, Perrod G, Hervieu V, Jaouen A, Charissoux A, Guillaud O, Legros R, Walter T, Saurin JC, Rivory J, Prat F, Lépilliez V, Ponchon T, Pioche M. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases. United European Gastroenterol J 2021;9:362-9. [PMID: 32903167 DOI: 10.1177/2050640620958903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Pech O. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges. Adv Exp Med Biol 2016;908:99-109. [PMID: 27573769 DOI: 10.1007/978-3-319-41388-4_6] [Reference Citation Analysis]
140 Funakawa K, Uto H, Sasaki F, Nasu Y, Mawatari S, Arima S, Nakazawa J, Taguchi H, Hashimoto S, Kanmura S, Setoyama H, Numata M, Tsubouchi H, Ido A. Effect of endoscopic submucosal dissection for superficial esophageal neoplasms and risk factors for postoperative stricture. Medicine (Baltimore). 2015;94:e373. [PMID: 25569662 DOI: 10.1097/md.0000000000000373] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
141 Wang KK, Prasad G, Tian J. Endoscopic mucosal resection and endoscopic submucosal dissection in esophageal and gastric cancers. Curr Opin Gastroenterol. 2010;26:453-458. [PMID: 20703112 DOI: 10.1097/mog.0b013e32833e4712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
142 Sato H, Inoue H, Kobayashi Y, Maselli R, Santi EG, Hayee B, Igarashi K, Yoshida A, Ikeda H, Onimaru M. Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma: oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc. 2013;78:250-257. [PMID: 23453294 DOI: 10.1016/j.gie.2013.01.008] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
143 Ramay FH, Vareedayah AA, Visrodia K, Iyer PG, Wang KK, Eluri S, Shaheen NJ, Reddy R, Martin LW, Greenwald BD, Edwards MA. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma? Ann Surg Oncol 2019;26:714-31. [DOI: 10.1245/s10434-018-07118-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
144 Shen W, Shen Y, Tan L, Jin C, Xi Y. A nomogram for predicting lymph node metastasis in surgically resected T1 esophageal squamous cell carcinoma. J Thorac Dis. 2018;10:4178-4185. [PMID: 30174862 DOI: 10.21037/jtd.2018.06.51] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
145 McLaren PJ, Dolan JP. Surgical Treatment of High-Grade Dysplasia and Early Esophageal Cancer. World J Surg 2017;41:1712-8. [PMID: 28258451 DOI: 10.1007/s00268-017-3958-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
146 Barbour AP, Jones M, Brown I, Gotley DC, Martin I, Thomas J, Clouston A, Smithers BM. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol. 2010;17:2494-2502. [PMID: 20349213 DOI: 10.1245/s10434-010-1025-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
147 Xue L, Ren L, Zou S, Shan L, Liu X, Xie Y, Zhang Y, Lu J, Lin D, Dawsey SM, Wang G, Lu N. Parameters predicting lymph node metastasis in patients with superficial esophageal squamous cell carcinoma. Mod Pathol. 2012;25:1364-1377. [PMID: 22627741 DOI: 10.1038/modpathol.2012.89] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
148 Miyawaki Y, Sato H, Fujiwara N, Oya S, Sugita H, Hirano Y, Yamane T, Sakuramoto S, Okamoto K, Yamaguchi S, Koyama I. Association of the primary tumor's SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study. Int J Clin Oncol 2020;25:561-9. [PMID: 31867680 DOI: 10.1007/s10147-019-01606-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
149 Schlosser T, Hoffmeister A, Feisthammel J, Niebisch S, Thieme R, Gockel I. [Treatment recommendations for early esophageal cancer : Endoscopic and surgical options]. Chirurg 2021;92:1077-84. [PMID: 34622303 DOI: 10.1007/s00104-021-01513-7] [Reference Citation Analysis]
150 Schölvinck D, Künzli H, Meijer S, Seldenrijk K, van Berge Henegouwen M, Bergman J, Weusten B. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc. 2016;30:4102-4113. [PMID: 27357927 DOI: 10.1007/s00464-016-5071-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
151 Ishihara R, Arima M, Iizuka T, Oyama T, Katada C, Kato M, Goda K, Goto O, Tanaka K, Yano T, Yoshinaga S, Muto M, Kawakubo H, Fujishiro M, Yoshida M, Fujimoto K, Tajiri H, Inoue H; Japan Gastroenterological Endoscopy Society Guidelines Committee of ESD/EMR for Esophageal Cancer. Endoscopic submucosal dissection/endoscopic mucosal resection guidelines for esophageal cancer. Dig Endosc 2020;32:452-93. [PMID: 32072683 DOI: 10.1111/den.13654] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 26.0] [Reference Citation Analysis]
152 Cowie A, Noble F, Underwood T. Strategies to improve outcomes in esophageal adenocarcinoma. Expert Rev Anticancer Ther 2014;14:677-87. [PMID: 24621143 DOI: 10.1586/14737140.2014.895668] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
153 Gockel I, Domeyer M, Sgourakis GG, Schimanski CC, Moehler M, Kirkpatrick CJ, Lang H, Junginger T, Hansen T. Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining. J Surg Oncol. 2009;100:191-198. [PMID: 19548259 DOI: 10.1002/jso.21336] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
154 Akutsu Y, Uesato M, Shuto K, Kono T, Hoshino I, Horibe D, Sazuka T, Takeshita N, Maruyama T, Isozaki Y, Akanuma N, Matsubara H. The Overall Prevalence of Metastasis in T1 Esophageal Squamous Cell Carcinoma: A Retrospective Analysis of 295 Patients. Annals of Surgery 2013;257:1032-8. [DOI: 10.1097/sla.0b013e31827017fc] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
155 Zhou Y, Du J, Wang Y, Li H, Ping G, Luo J, Chen L, Zhang S, Wang W. Prediction of lymph node metastatic status in superficial esophageal squamous cell carcinoma using an assessment model combining clinical characteristics and pathologic results: A retrospective cohort study. International Journal of Surgery 2019;66:53-61. [DOI: 10.1016/j.ijsu.2019.04.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
156 Shimizu H, Arimura Y, Onodera K, Takahashi H, Okahara S, Kodaira J, Oohashi H, Isshiki H, Kawakami K, Yamashita K, Shinomura Y, Hosokawa M. Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling. PLoS One 2016;11:e0149327. [PMID: 26889682 DOI: 10.1371/journal.pone.0149327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
157 Grotenhuis BA, van Heijl M, Zehetner J, Moons J, Wijnhoven BP, van Berge Henegouwen MI, Tilanus HW, DeMeester TR, Lerut T, van Lanschot JJ. Surgical management of submucosal esophageal cancer: extended or regional lymphadenectomy? Ann Surg 2010;252:823-30. [PMID: 21037438 DOI: 10.1097/SLA.0b013e3181fcd730] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
158 Singh A, Chak A. Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma. Gastroenterol Rep (Oxf). 2015;3:303-315. [PMID: 26486568 DOI: 10.1093/gastro/gov048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
159 Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M. Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus. 2019;16:25-43. [PMID: 30171414 DOI: 10.1007/s10388-018-0642-8] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 29.3] [Reference Citation Analysis]
160 Miyata H, Sugimura K, Motoori M, Omori T, Yamamoto K, Yanagimoto Y, Shinno N, Yasui M, Takahashi H, Wada H, Ohue M, Yano M. Clinical features of metastasis from superficial squamous cell carcinoma of the thoracic esophagus. Surgery 2019;166:1033-40. [PMID: 31493901 DOI: 10.1016/j.surg.2019.07.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
161 Fountoulakis A, Souglakos J, Vini L, Douridas GN, Koumarianou A, Kountourakis P, Agalianos C, Alexandrou A, Dervenis C, Gourtsoyianni S, Gouvas N, Kalogeridi M, Levidou G, Liakakos T, Sgouros J, Sgouros SN, Triantopoulou C, Xynos E. Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer. Updates Surg 2019;71:599-624. [DOI: 10.1007/s13304-019-00696-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
162 Gong L, Yue J, Duan X, Jiang H, Zhang H, Zhang X, Yu Z. Comparison of the therapeutic effects of endoscopic submucosal dissection and minimally invasive esophagectomy for T1 stage esophageal carcinoma. Thorac Cancer 2019;10:2161-7. [PMID: 31556243 DOI: 10.1111/1759-7714.13203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]